Advisor Group Holdings, Inc. Precipio, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.33 - $0.7 $21 - $46	66 Added 8.78%	818 $0
Q2 2022 Aug 10, 2022	SELL	$0.98 - $1.68 $7,938 - $13,608	-8,100 Reduced 91.5%	752 $1,000
Q1 2022 May 04, 2022	BUY	$1.19 - $1.71 $1,608 - $2,311	1,352 Added 18.03%	8,852 $12,000
Q3 2021 Nov 05, 2021	BUY	$2.78 - $3.63 $18,992 - $24,800	6,832 Added 1022.75%	7,500 $21,000
Q2 2021 Aug 02, 2021	SELL	$1.8 - $5.25 $9,720 - $28,350	-5,400 Reduced 88.99%	668 $2,000
Q1 2021 May 13, 2021	BUY	$2.1 - $3.89 $2,100 - $3,890	1,000 Added 19.73%	6,068 $14,000
Q4 2020 Feb 10, 2021	BUY	$1.94 - $2.64 $9,700 - $13,200	5,000 Added 7352.94%	5,068 $10,000
Q1 2020 May 18, 2020	BUY	$0.68 - $2.3 $46 - $156	68 New	68 $0

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $120M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.